More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces New 3G CBD Vitality Oral Concentrate

Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces New 3G CBD Vitality Oral Concentrate

by adminAdrianRamirez | Dec 19, 2018 | Press Releases

SAN DIEGO, Dec. 19, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health today announced the launch of its latest cannabidiol (CBD) pet product, Phyto Animal...
Leafly, The Street, and Others Feature News from Medical Marijuana, Inc.

Leafly, The Street, and Others Feature News from Medical Marijuana, Inc.

by adminAdrianRamirez | Dec 14, 2018 | HempMeds Brasil, HempMeds Mexico, Kannaway, Media Coverage

Changes to U.S. hemp policy, medical cannabis classes in Brazil, and legalized cannabis in Mexico among our headlines this week. Cannabis policy is changing around the world, and Medical Marijuana, Inc. and our family of companies is at the forefront, promoting safe,...
Medical Marijuana, Inc. Included in Real Money’s “Top 5 Hemp Companies” to Benefit from Farm Bill

Medical Marijuana, Inc. Included in Real Money’s “Top 5 Hemp Companies” to Benefit from Farm Bill

by adminAdrianRamirez | Dec 12, 2018 | Kannaway, Media Coverage

Medical Marijuana, Inc. was highlighted in a new article that explores the impact of the passing of the 2018 Farm Bill on hemp and CBD. Medical Marijuana, Inc. was included in a list of the top five hemp companies to benefit the most from the 2018 Farm Bill in an...
Medical Marijuana, Inc. Subsidiary Phyto Animal Health to Exhibit and Speak at Fetch DVM360 Conference

Medical Marijuana, Inc. Subsidiary Phyto Animal Health to Exhibit and Speak at Fetch DVM360 Conference

by adminAdrianRamirez | Dec 12, 2018 | Press Releases

SAN DIEGO, Dec. 12, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health announced today that it will be sponsoring and exhibiting its line of cannabidiol (CBD) hemp oil...
Medical Marijuana, Inc. and Subsidiaries Kannaway® and Phyto Animal Health Announce November 2018 as the Largest Revenue Month in Company History

Medical Marijuana, Inc. and Subsidiaries Kannaway® and Phyto Animal Health Announce November 2018 as the Largest Revenue Month in Company History

by adminAdrianRamirez | Dec 11, 2018 | Kannaway, Press Releases

SAN DIEGO, Dec. 11, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced November as the largest-ever (unaudited) sales month in its history. Subsidiaries Kannaway® and Phyto Animal...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.